Bafna Pharmaceuticals

72.92
0.00
(0.00%)
Market Cap
172.50 Cr
EPS
-15.52
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
113.00
52 Week low
69.00
PB Ratio
3.33
Debt to Equity
0.70
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,648.35 3,95,494.38 33.96 49,887.20 12.06 9,648 13.77 37.74
5,771.95 1,53,227.14 76.76 8,184.00 0.89 1,600 64.53 51.57
1,474.05 1,19,046.35 23.95 26,520.70 14.17 4,155 47.38 51.15
3,039.20 1,02,860.34 56.24 10,785.70 11.59 1,656 13.54 45.77
1,152.35 96,153.34 18.19 28,905.40 12.36 5,578 1.69 30.83
2,320.10 95,719.65 47.43 10,615.60 19.57 1,942 -16.38 39.42
888.40 89,393.83 19.98 19,831.50 13.82 3,831 29.92 36.77
1,928.00 87,954.89 31.47 20,141.50 19.94 1,936 38.82 38.83
1,105.00 64,178.58 18.47 29,559.20 17.55 3,169 -10.04 42.81
28,880.00 61,367.98 46.85 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
-2.95 %
Net Income Growth
-90.21 %
Cash Flow Change
-1,816.76 %
ROE
-96.42 %
ROCE
-90.07 %
EBITDA Margin (Avg.)
-112.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Jun 2019
Sept 2019
Revenue
12
9
7
12
Expenses
14
9
10
12
EBITDA
-2
0
-3
0
Operating Profit %
-15 %
2 %
-42 %
-3 %
Depreciation
1
1
1
1
Interest
1
1
0
0
Profit Before Tax
-4
-1
-4
-1
Tax
0
0
-2
0
Net Profit
-4
-1
-2
-1
EPS in ₹
0.00
-0.80
-0.90
-0.25

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
Total Assets
200
193
178
138
120
71
Fixed Assets
55
53
49
45
37
35
Current Assets
127
123
77
49
49
36
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
17
0
0
0
Other Assets
145
140
113
94
82
36
Total Liabilities
200
193
178
138
120
71
Current Liabilities
111
95
82
60
71
17
Non Current Liabilities
16
40
55
41
30
3
Total Equity
73
58
42
37
19
51
Reserve & Surplus
53
39
20
14
-5
-7
Share Capital
19
19
19
24
24
2

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
Net Cash Flow
0
-0
-0
0
-0
6
Investing Activities
60
-0
-5
38
15
33
Operating Activities
11
1
-1
-7
-2
-34
Financing Activities
-71
-1
6
-31
-14
7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
91.74 %
90.39 %
90.40 %
90.42 %
90.42 %
90.12 %
90.00 %
90.02 %
90.00 %
90.00 %
88.74 %
88.43 %
88.30 %
88.30 %
88.30 %
88.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.31 %
6.23 %
6.26 %
6.10 %
5.24 %
5.50 %
5.62 %
5.61 %
5.64 %
5.64 %
6.87 %
7.66 %
7.48 %
7.37 %
7.69 %
7.66 %
Others
1.95 %
3.37 %
3.34 %
3.49 %
4.33 %
4.38 %
4.38 %
4.37 %
4.37 %
4.36 %
4.39 %
3.91 %
4.23 %
4.34 %
4.01 %
4.04 %
No of Share Holders
8,603
8,330
8,068
7,910
7,326
7,223
7,275
7,199
7,120
6,992
7,354
7,367
7,539
7,391
7,295
7,214

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Technical Indicators

RSI(14)
Neutral
40.28
ATR(14)
Less Volatile
4.13
STOCH(9,6)
Neutral
21.48
STOCH RSI(14)
Neutral
23.35
MACD(12,26)
Bearish
-0.68
ADX(14)
Weak Trend
18.05
UO(9)
Bearish
37.78
ROC(12)
Downtrend And Accelerating
-9.75
WillR(14)
Neutral
-72.00